Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

PHASE2TerminatedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 29, 2012

Study Completion Date

October 29, 2012

Conditions
Colorectal Cancer
Interventions
DRUG

CS-7017

CS-7017

DRUG

Placebo

Placebo

Trial Locations (39)

170

H.Clinic I Provincial de Barcelona, Barcelona

10060

Institute for Cancer Research and Treatment - IRCC, Candiolo

31008

Clinica Universitaria de Navarra, Pamplona

33100

Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine

35042

Service d'Oncologie Medicale, Rennes

35768

Centre Hospitalier Prive Saint Gregoire, Saint-Grégoire

40005

Sumy Regional Oncology Center, Sumy

53100

Policlinico Santa Maria alle Scotte, Siena

62500

Fakulti nemocnice Brno, Brno

66902

Nemocnice Znojmo, p.o., Oddeleni radiacni a klinicke onkologie, Znojmo

68024

Hopitaux civils de colmar, Colmar

69437

Hopital Edouard Herriot, Lyon

77520

Fakultni nemocnice Olomouc, Olomouc

81675

Klinikum rechts der Isar, München

86609

Onkologische Praxis Donauwörth, Donauwörth

115478

Russian Oncology Research Centre n.a. Blokhin, RAMS, Moscow

125367

Central Clinical Hospital #1, Moscow

129128

NUZ Semashko Central Clinical Hospital, Moscow

194291

Federal State Institution of Healthcare Clinical Hospital # 122 n.a.L.G Sokolov, Saint Petersburg

198255

St-Petersburg State Institution of Public Health, Saint Petersburg

249030

Medical Radiological Research Centre, Obninsk

300053

Tula Regional Oncology dispensary, Tula

4200111

Kazan State Medical University, Kazan'

06120

Universitätsklinikum Halle Klinik und Poliklinik für Innere Medizin, Halle

Unknown

Ospedale San Martino, Genova

Unita Operativa di Oncologia Medica, Lecce

Volyn regional oncology dispensary, Lutsk

15-027

Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie w Bialymstoku, Bialystok

41-902

Wojewodzki Szpital Specjalistyczny, Bytom

44-101

Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Gliwice

31-108

VESALIUS Sp. z o.o., Krakow

01-002

NZOZ ONKOLOG s.c., Warsaw

08221

Hospital Mútua de Terrassa, Terrassa (Barcelona)

03115

Kyiv City Oncology Hospital, Kiev

HA6 2RN

Mount Vernon Cancer Centre, Northwood

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

EC1A 7BE

St.Bartholomew's Hospital, London

NW1 2PQ

UCLH Cancer Clinical Trials Unit, London

M20 4BX

Christie Hospital, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00986440 - Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy | Biotech Hunter | Biotech Hunter